Cyclerion Therapeutics, Inc. (CYCN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$97.50M2019: -$102.22M2020: -$72.49M2021: -$36.52M2022: -$40.61M2023: -$21.25M2024: -$4.33M2025: -$3.31M-$3.31M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$3.31M+23.5%
2024-$4.33M+79.6%
2023-$21.25M+47.7%
2022-$40.61M-11.2%
2021-$36.52M+49.6%
2020-$72.49M+29.1%
2019-$102.22M-4.8%
2018-$97.50M